| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Medical Oncology [J. H. L., J. J. K., D. M. W.], Department of Gynecology [J. T. W.], and Department of Clinical Immunology and Biological Therapy [M. B.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030
Recently, tumor-specific allele loss has been shown to be an important characteristic of some tumors. When such loss includes one or more growth-regulatory genes, it may allow the expression of tumorigenicity. Using Southern blots, we analyzed normal and tumor DNA samples from 19 ovarian cancer patients, using a series of polymorphic DNA probes that map to a variety of chromosomal loci. Of 14 informative cases, tumor-specific allelic loss was observed in nine (64%) at the estrogen receptor (ESR) gene locus on chromosome 6q. On chromosome 17p at the D17S28 and D17S30 loci, allelic losses were also detected in 6 of 8 (75%) and 9 of 14 (64%) cases, respectively. Allelic loss at the HRAS1 gene locus on chromosome 11p occurred in 5 of 11 (46%) informative cases. The relatively high incidence of these allelic losses observed on chromosome 6q represents the first implication by molecular genetic analysis of this chromosomal region in a human malignancy, and it thus appears to be a genetic change specific to ovarian carcinoma. DNA sequence losses on 11p and 17p, also reported for other cancers, may reflect the presence of tumor- or growth-suppressor genes on these chromosomes that are important in the genesis of many tumor types, including ovarian malignancies.
1 Supported by an Institutional Research Grant, The University of Texas M. D. Anderson Cancer Center, Houston, TX, and the Bessie Frisch Memorial Fund.
2 To whom requests for reprints should be addressed, at Molecular Analysis Incorporated, 8000 El Rio, Houston, TX 77054.
Received 6/ 9/89.
Revised 12/21/89.
This article has been cited by other articles:
![]() |
Y. Takahashi, Y. Miyoshi, C. Takahata, N. Irahara, T. Taguchi, Y. Tamaki, and S. Noguchi Down-Regulation of LATS1 and LATS2 mRNA Expression by Promoter Hypermethylation and Its Association with Biologically Aggressive Phenotype in Human Breast Cancers Clin. Cancer Res., February 15, 2005; 11(4): 1380 - 1385. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. W. Wang, D. A. Bell, R. S. Berkowitz, and S. C. Mok Whole Genome Amplification and High-Throughput Allelotyping Identified Five Distinct Deletion Regions on Chromosomes 5 and 6 in Microdissected Early-Stage Ovarian Tumors Cancer Res., May 1, 2001; 61(10): 4169 - 4174. [Abstract] [Full Text] |
||||
![]() |
R. L. Baldwin, E. Nemeth, H. Tran, H. Shvartsman, I. Cass, S. Narod, and B. Y. Karlan BRCA1 Promoter Region Hypermethylation in Ovarian Carcinoma: A Population-based Study Cancer Res., October 1, 2000; 60(19): 5329 - 5333. [Abstract] [Full Text] |
||||
![]() |
A. Schneider, S. Borgnat, H. Lang, O. Régine, V. Lindner, M. Kassem, C. Saussine, P. Oudet, D. Jacqmin, and M. P. Gaub Evaluation of Microsatellite Analysis in Urine Sediment for Diagnosis of Bladder Cancer Cancer Res., August 1, 2000; 60(16): 4617 - 4622. [Abstract] [Full Text] |
||||
![]() |
N. Mori, R. Morosetti, E. Hoflehner, M. Lubbert, H. Mizoguchi, and H. P. Koeffler Allelic Loss in the Progression of Myelodysplastic Syndrome Cancer Res., June 1, 2000; 60(11): 3039 - 3042. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-P. Kim, J.-H. Roe, P. B. Chock, and M. B. Yim Transcriptional Activation of the Human Manganese Superoxide Dismutase Gene Mediated by Tetradecanoylphorbol Acetate J. Biol. Chem., December 24, 1999; 274(52): 37455 - 37460. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hatta, Y. Yamada, M. Tomonaga, I. Miyoshi, J. W. Said, and H. P. Koeffler Detailed Deletion Mapping of the Long Arm of Chromosome 6 in Adult T-Cell Leukemia Blood, January 15, 1999; 93(2): 613 - 616. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hatta, Y. Yamada, M. Tomonaga, J. W. Said, I. Miyosi, and H. P. Koeffler Allelotype Analysis of Adult T-Cell Leukemia Blood, September 15, 1998; 92(6): 2113 - 2117. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |